November 18, 2026 · The American journal of cardiology · DOI: 10.1016/j.amjcard.2026.11.014

Immune checkpoint inhibitors-induced -induced vs. Conventional Myocarditis: Navigating Pathophysiological and Clinical Divergences.

Listen to this summary

This review compares immune checkpoint inhibitor-induced myocarditis (ICI-M) with conventional myocarditis (CM) to determine how their pathophysiology, clinical presentation, diagnosis, and management differ. The authors find that ICI-M is a hyper-acute, T-cell-mediated toxicity that arises early (within 30-60 days) and carries higher mortality and conduction/arrhythmic risk, often with non-specific symptoms, preserved ejection fraction, and overlap with myositis. They conclude that advanced imaging (GLS, CMR parametric mapping), immediate ICI discontinuation with high-dose immunosuppression, and dedicated cardio-oncology pathways are needed for early recognition and improved outcomes.

Raffaella Mistrulli, Erika Pagannone, Francesco Sorana, Andrea Messina, Davide D'Anna, Ilaria Rubino, Eleonora Zuppini, Marco Fornelli, Marco Di Francesco, Nicola Tartaglia, Emanuele Gallinoro, Marta Belmonte, Pasquale Paolisso, Allegra Battistoni, Emanuele Barbato

This is one of 33,000+ journals available on OSLR. Try it free for 14 days.

Free 14-day trial. 33,000+ journals. Cancel anytime.

14-day free trial. No commitment.

“

"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."

Dr. Jennifer Thompson

Dr. Jennifer Thompson

Portland, OR

Stay current without falling behind

33,000+ journals. 3-minute audio summaries. Free for 14 days.

Download on the App StoreGet it on Google Play